Procedure for Stability Testing in High-Volume Drug Manufacturing
1) Purpose
The purpose of this SOP is to outline the procedure for conducting stability testing for high-volume drug products in compliance with regulatory guidelines. This ensures that drug products maintain their quality, safety, and efficacy throughout their shelf life, even under large-scale production conditions.
2) Scope
This SOP applies to all personnel involved in the stability testing of high-volume drug products, including formulation development, quality control, and regulatory affairs teams.
3) Responsibilities
Manufacturing Team: Responsible for producing batches that are representative of high-volume production.
Stability Study Team: Responsible for conducting stability studies according to approved protocols.
Quality Assurance Team: Responsible for reviewing stability data to ensure it complies with regulatory guidelines.
4) Procedure
4.1 Protocol Development
4.1.1 Develop a stability testing protocol that includes parameters relevant to high-volume manufacturing, such as assay, impurity profile, dissolution,
and physical characteristics.4.1.2 Define storage conditions (e.g., room temperature, accelerated) and testing intervals (e.g., 0, 3, 6, 12 months) based on regulatory guidelines.
4.2 Sample Preparation and Storage
4.2.1 Prepare samples from multiple production batches to ensure that they are representative of high-volume manufacturing conditions.
4.2.2 Store samples under specified conditions, with continuous monitoring to
4.3 Conducting Stability Tests
4.3.1 Perform stability tests at all required intervals, focusing on parameters that could be impacted by scale-up and high-volume production.
4.3.2 Document all data accurately and ensure compliance with the approved protocol.
4.4 Data Analysis and Reporting
4.4.1 Analyze stability data to identify any trends or deviations that could impact product quality in high-volume manufacturing scenarios.
4.4.2 Prepare a comprehensive stability report for regulatory submission, detailing all findings and conclusions.
5) Abbreviations, if any
QA: Quality Assurance
6) Documents, if any
6.1 Stability testing protocols
6.2 Data sheets
6.3 Stability reports
7) Reference, if any
FDA Guidance for Industry: Stability Testing of High-Volume Drug Products
8) SOP Version
Version 1.0

